Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Silver North Intersects 1.83 metres True Width of 1,088 g/t Silver, 3.90 g/t Gold (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare
Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,... see more

GREY:ATBPF - Post Discussion

Antibe Therapeutics Inc(Pre-Merger) > FDA applications ???
View:
Post by MrMugsy on May 02, 2022 9:14am

FDA applications ???

With CITA scratched of the "to do" list ... seems fast-track and/or breakthrough therapy designation applications should be filled out before fall.  Thinking we'll have the information required to do so.

Maybe a few words about fast-track tomorrow ?  Would be nice.
Comment by Doccole on May 02, 2022 12:37pm
Glad to see this gone. it would be nice to have some news that would end this death spiral.  I mean, I continue to pick up shares.  Im about double what I wanted to be at....which is great, because I'll be in decent shape when they have a reverse split haha! good news today, even though the market doesn't care.
Comment by MrMugsy on May 02, 2022 12:43pm
Market won't care as they don't know how to read it. It's only a psychological barrier for future Institutional Investors. All barriers out of the way accept valuation. Now - all eyes on 346 - that's the key to everything.  How big is 346?
Antibe Therapeutics Inc(Pre-Merger)